Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Market Cap	323.74B
Revenue (ttm)	614.94B
Net Income (ttm)	-4.58B
Shares Out	27.93M
EPS (ttm)	-163.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,300
Average Volume	38,586
Open	11,780
Previous Close	11,560
Day's Range	11,400 - 11,780
52-Week Range	10,300 - 20,500
Beta	1.09
RSI	54.07
Earnings Date	Apr 30, 2025

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 1,033
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 249420

Financial Performance

In 2024, Ildong Pharmaceutical's revenue was 614.94 billion, an increase of 2.36% compared to the previous year's 600.76 billion. Losses were -4.58 billion, -94.20% less than in 2023.